{"id":26887,"date":"2022-03-07T16:53:13","date_gmt":"2022-03-07T16:53:13","guid":{"rendered":"https:\/\/lscconnect.com\/consultantconnect\/?p=26887"},"modified":"2022-03-23T12:06:40","modified_gmt":"2022-03-23T12:06:40","slug":"life-science-industry-news-february-2022","status":"publish","type":"post","link":"https:\/\/lscconnect.com\/consultantconnect\/blog\/2022\/03\/07\/life-science-industry-news-february-2022\/","title":{"rendered":"LIFE SCIENCE INDUSTRY NEWS\u00a0 – MARCH 2022"},"content":{"rendered":"
<\/p>\n
<\/p>\n
<\/p>\n
At LSC we’re dedicated to the Life Sciences and here to keep you up to date with the latest news, projects and learning opportunities within the industry.<\/p>\n
Many exciting developments this month. Cerenovus, a unit of Johnson & Johnson, has invested $5 million in its Galway facility. The investment is expected to create more than 30 new specialized roles at Cerenovus Galway. We also look back at some of the industry’s leading companies, such as Lilly and MSD, have adopted a flexible, inclusive approach to work, which has been a major factor in their success and expansion in Ireland during Covid-19.<\/p>\n
<\/p>\n
<\/p>\n
Pharmaceutical manufacturer Novartis has reached an agreement with UK firm Sterling Pharma Solutions to divest its facility in Ringaskiddy in Cork<\/p>\n
(read more)<\/a><\/p>\n <\/p>\n Mairead McCaul, of MSD Ireland, explains how the company is future-proofing its business from Ireland to the world<\/p>\n (read more)<\/a><\/p>\n <\/p>\n Pharma giant announces that it \u201cwill continue\u201d its flexible, inclusive approach post-Covid<\/p>\n (read more)<\/a><\/p>\n <\/p>\n Cerenovus\u00a0is to create at least 30 specialised jobs as part of a \u20ac50 million investment at its Galway plant over the next three years<\/span><\/p>\n (read more)<\/a><\/p>\n <\/p>\n Ireland is in world’s top 10 for universities meeting the needs of a competitive economy, plus 25-34 year-olds with a third level qualification above the EU average<\/span><\/p>\n (read more)<\/a><\/p>\n <\/p>\n Health equity is a priority for Gilead Sciences, who work hard to ensure global access to their HIV and viral hepatitis medicines<\/span><\/p>\nMSD \u2014 driving the future of bio-pharma in Ireland<\/strong><\/h2>\n
Eli Lilly: Pioneers in supporting women in leadership<\/h2>\n
J&J Cerenovus to create 30 jobs as part of \u20ac50m investment in Galway<\/strong><\/h2>\n
Cork delivers for US business, says Pfizer and AmCham leader<\/strong><\/h2>\n
Global ambition, local action at Gilead<\/strong><\/h2>\n